David Brown

4.6k total citations · 3 hit papers
71 papers, 3.5k citations indexed

About

David Brown is a scholar working on Molecular Biology, Organic Chemistry and Immunology. According to data from OpenAlex, David Brown has authored 71 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 14 papers in Organic Chemistry and 8 papers in Immunology. Recurrent topics in David Brown's work include Glycosylation and Glycoproteins Research (6 papers), Phosphodiesterase function and regulation (5 papers) and Mitochondrial Function and Pathology (4 papers). David Brown is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Phosphodiesterase function and regulation (5 papers) and Mitochondrial Function and Pathology (4 papers). David Brown collaborates with scholars based in United Kingdom, United States and Australia. David Brown's co-authors include Kathy K. Griendling, Andrew Bell, N.K. Terrett, Peter Ellis, Ruth M.E. Chalmers-Redman, W. G. Tatton, Nadine Tatton, Susan Ortlepp, D. Andrew and Hugh Rosen and has published in prestigious journals such as Circulation, The EMBO Journal and The Journal of Immunology.

In The Last Decade

David Brown

69 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nox proteins in signal transduction

2009 672 citations David Brown, Kathy K. Griendling Free Radical Biology and Medicine profile →
Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction

1996 516 citations N.K. Terrett, David Brown et al. profile →
Regulation of Signal Transduction by Reactive Oxygen Species in the Cardiovascular System

2015 400 citations David Brown, Kathy K. Griendling profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Brown United Kingdom	24	1.3k	581	565	535	257	71	3.5k
Gary P. O’Neill Canada	38	2.0k 1.5×	546 0.9×	508 0.9×	986 1.8×	211 0.8×	80	6.1k
Arnold Stern United States	34	1.8k 1.4×	254 0.4×	335 0.6×	807 1.5×	87 0.3×	115	3.8k
Tomoko Nakamura Japan	36	1.5k 1.1×	191 0.3×	432 0.8×	196 0.4×	157 0.6×	187	4.3k
Stephen J. Taylor United Kingdom	35	3.9k 3.0×	376 0.6×	362 0.6×	460 0.9×	531 2.1×	115	5.7k
Masayuki Niwa Japan	33	1.7k 1.3×	143 0.2×	520 0.9×	464 0.9×	65 0.3×	197	3.8k
Michael D. Davis United States	31	2.3k 1.7×	239 0.4×	530 0.9×	559 1.0×	85 0.3×	100	3.9k
Robert Fürst Germany	32	1.4k 1.1×	321 0.6×	345 0.6×	206 0.4×	61 0.2×	119	3.7k
William G. Christen United States	41	1.2k 0.9×	112 0.2×	145 0.3×	459 0.9×	109 0.4×	103	5.5k
David K. Johnson United States	30	712 0.5×	379 0.7×	431 0.8×	346 0.6×	51 0.2×	127	2.8k
Hiroshi Takeuchi Japan	34	1.6k 1.2×	185 0.3×	192 0.3×	441 0.8×	169 0.7×	186	3.8k

Countries citing papers authored by David Brown

Since Specialization

Citations

This map shows the geographic impact of David Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Brown more than expected).

Fields of papers citing papers by David Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Brown. The network helps show where David Brown may publish in the future.

Co-authorship network of co-authors of David Brown

This figure shows the co-authorship network connecting the top 25 collaborators of David Brown. A scholar is included among the top collaborators of David Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Brown. David Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brown, David, et al.. (2025). Bortezomib for the treatment of anti-N-methyl-d-aspartate receptor encephalitis in a patient with psoriatic arthritis receiving adalimumab: A case report and literature review. Journal of Neuroimmunology. 409. 578754–578754.

Wachter, Stefanie, David Brown, Leslie S. Wolfe, et al.. (2023). Application of platform process development approaches to the manufacturing of Mabcalin™ bispecifics. Journal of Biotechnology. 377. 13–22. 3 indexed citations

Jephcote, Calvin, David Brown, Thomas Verbeek, & Alice Mah. (2020). A systematic review and meta-analysis of haematological malignancies in residents living near petrochemical facilities. Environmental Health. 19(1). 53–53. 34 indexed citations

Brown, David, Traci L. Parry, & Monte S. Willis. (2017). Ubiquitin Ligases and Posttranslational Regulation of Energy in the Heart: The Hand that Feeds. Comprehensive physiology. 7(3). 841–862. 9 indexed citations

Xu, Qian, Amol A. Kulkarni, Ayyiliath M. Sajith, et al.. (2017). Design, synthesis, and biological evaluation of inhibitors of the NADPH oxidase, Nox4. Bioorganic & Medicinal Chemistry. 26(5). 989–998. 22 indexed citations

Brown, David, et al.. (2017). A Phase IC Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Cognitive Outcomes of BI 409306 in Patients with Mild-to-Moderate Schizophrenia. Neurology and Therapy. 7(1). 129–139. 6 indexed citations

Quintana, Megan T., James R. Bain, Michael J. Muehlbauer, et al.. (2016). Cessation of biomechanical stretch model of C2C12 cells models myocyte atrophy and anaplerotic changes in metabolism using non-targeted metabolomics analysis. The International Journal of Biochemistry & Cell Biology. 79. 80–92. 16 indexed citations

Brown, David, Brian C. Cooley, Megan T. Quintana, Cynthia Lander, & Monte S. Willis. (2016). Nebulized Delivery of the MAPKAP Kinase 2 Peptide Inhibitor MMI-0100 Protects Against Ischemia-Induced Systolic Dysfunction. International Journal of Peptide Research and Therapeutics. 22(3). 317–324. 8 indexed citations

Brown, David, et al.. (2014). The Effect of Principal's Leadership Style on School Environment and Outcome.. Research in higher education journal. 22. 22 indexed citations

10.

Horton, Daniel L., Sebastian Lucas, David Brown, et al.. (2014). Diagnosis, management and post-mortem findings of a human case of rabies imported into the United Kingdom from India: a case report. Virology Journal. 11(1). 63–63. 9 indexed citations

11.

Vito, Giuseppe De, Ciara Hughes, George A. Burke, et al.. (2013). Effects of α-lipoic Acid on mtDNA Damage after Isolated Muscle Contractions. Medicine & Science in Sports & Exercise. 45(8). 1469–1477. 16 indexed citations

12.

Baroody, Fuad M., et al.. (2011). Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis. Journal of Allergy and Clinical Immunology. 127(4). 927–934. 64 indexed citations

13.

Martín-Garrido, Abel, David Brown, Alicia N. Lyle, et al.. (2010). NADPH oxidase 4 mediates TGF-β-induced smooth muscle α-actin via p38MAPK and serum response factor. Free Radical Biology and Medicine. 50(2). 354–362. 81 indexed citations

14.

Tatton, W. G., Ruth M.E. Chalmers-Redman, David Brown, & Nadine Tatton. (2003). Apoptosis in Parkinson's disease: Signals for neuronal degradation. Annals of Neurology. 53(S3). S61–S72. 310 indexed citations

15.

Slater, Michael D., David Brown, & Andy Husband. (2002). In the prostatic epithelium, dietary isoflavones from red clover significantly increase estrogen receptor β and E-cadherin expression but decrease transforming growth factor β1. Prostate Cancer and Prostatic Diseases. 5(1). 16–21. 12 indexed citations

16.

Brown, David, Paul Butler, Peter Ellis, et al.. (1995). The in vivo pharmacological profile of a 5‐HT₁ receptor agonist, CP‐122, 288, a selective inhibitor of neurogenic inflammation. British Journal of Pharmacology. 116(5). 2385–2390. 32 indexed citations

17.

Waterton, John C., Vasanthan Rajanayagam, Brian D. Ross, et al.. (1993). Magnetic resonance methods for measurement of disease progression in rheumatoid arthritis. Magnetic Resonance Imaging. 11(7). 1033–1038. 32 indexed citations

18.

Ormerod, M.G., Xiaoming Sun, David Brown, Roger T. Snowden, & Gerald M. Cohen. (1993). Quantification of Apoptosis and Necrosis by Flow Cytometry. Acta Oncologica. 32(4). 417–424. 79 indexed citations

19.

Crolla, John A., David Brown, & David G. Whittingham. (1990). Spontaneous induction of an homologous Robertsonian translocation, Rb(11.11) in a murine embryonic stem cell line. Genetics Research. 55(2). 107–110. 8 indexed citations

20.

Danilewicz, John C., Paul L. Barclay, I. T. Barnish, et al.. (1989). UK-69, 578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic. Biochemical and Biophysical Research Communications. 164(1). 58–65. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact